Sarepta Therapeutics (SRPT) Said to Price $300M at $59.75 - Feurstein

September 22, 2016 5:38 PM EDT

Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.

Sarepta Therapeutics (NASDAQ: SRPT) offering 4-5x oversubscribed, offering $300 million at $59.75, Adam Feurstein tweets citing a source.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Equity Offerings, FDA, Momentum Movers, Trader Talk

Related Entities

Adam Feuerstein

Add Your Comment